RESEARCH-USE BIOSIMILAR ANTIBODY

Azintuxizumab

Antibody-drug conjugate · IgG1

SLAMF7IgG1RUO

Azintuxizumab is an anti-SLAMF7 human IgG4κ monoclonal antibody. Azintuxizumab can be used in the synthesis of antibody-drug conjugate (ADC), Azintuxizumab vedotin.

TARGETSLAMF7
YAntibody-drug conjugate
CATALOGSC-BS-752
CATALOG NUMBERSC-BS-752
MOLECULAR WEIGHTApprox. 145.32 kDa
PRODUCT FORMATAntibody-drug conjugate

A research-use configuration for comparative antibody studies

Azintuxizumab is an anti-SLAMF7 human IgG4κ monoclonal antibody. Azintuxizumab can be used in the synthesis of antibody-drug conjugate (ADC), Azintuxizumab vedotin.

Azintuxizumab is a recombinant research-use antibody directed against SLAMF7.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Azintuxizumab | StellaCyte